A hearing will get underway in Delaware later today in the latest phase of GSK’s attempts to defend itself from allegations that its Zantac drug caused cancer in patients. The three-day hearing ...

The first lawsuit claiming that gastrointestinal drug Zantac causes cancer has been voluntarily dismissed a week before it was due to come to trial, in an early victory for the pharma companies ...

Background—H 2 receptor blockers and proton pump inhibitors reduce intestinal output in patients with short bowel syndrome. Aims—To evaluate the effect of intravenous omeprazole and ranitidine on ...

Background and Aims: Since the publication of the Asia-Pacific GERD consensus in2004, more data concerning the epidemiology and management of gastroesophageal refluxdisease (GERD) have emerged. An ...

Seed DS-01 contains a comprehensive blend of probiotics. Each 2-capsule serving delivers 24 different probiotic strains, including Lactiplantibacillus plantarum and Bifidobacterium lactis ...

In addition to being formulated for maximum absorption, we like that this supplement only requires one capsule per day and is free from artificial colors, flavors, and preservatives. According to ...

In the year 1988, the company commenced the production of bulk drug Ranitidine at Ankleshwar ... the installed capacity of Tablets and Capsules from 6750 million nos to 6950 million nos.

Background: We investigated the potential interactions between esomeprazole and a non-selective nonsteroidal anti-inflammatory drug (NSAID; naproxen) or a cyclo-oxygenase (COX)-2-selective NSAID ...